Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 461
Immune Disorders Drugs 195
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 116
Endocrine and Metabolic Disorders Drugs 103
Central Nervous System Drugs 102
Drug Discovery 101
Musculoskeletal Disorders Drugs 92
Pharmaceuticals 89
Clinical Trials 89
Hematological Drugs 83
Leukemia Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 63
Dermatological Drugs 58
Diabetes Drugs 54
Skin Cancer Drugs 49
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Infusions and Injectables 30
Pharmaceutical Manufacturing 27
Analgesics 25
Bladder Cancer Drugs 24
Drugs by Therapeutic Area 23
Antibiotics 23
Kidney Cancer Drugs 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Uterine Cancer Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 4
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



286 reviews

2,373 Results (Page 16 of 119)
- Relevance
  Sort by

Non-Small Cell Lung Cancer Market by Type, Treatment Type, Distribution Channel, and Geography: Forecast up to 2027

 Report
July 2023
223 Pages
Global

From

€4152EUR$4,500USD£3,506GBP

Glioblastoma Multiforme (GBM) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1036 Pages
Global

From

€2307EUR$2,500USD£1,948GBP

Medulloblastoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
143 Pages
Global

From

€1845EUR$2,000USD£1,558GBP

Anti-Asthmatics and COPD Drugs Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4143EUR$4,490USD£3,498GBP

Medulloblastoma- Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1384EUR$1,500USD£1,169GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Co-promotion and Co-marketing in Pharmaceuticals and Biotechnology 2016-2026

 Report
September 2026
300 Pages
Global

From

€3686EUR$3,995USD£3,112GBP

Organ Transplant Immunosuppressant Drugs Market - Global Forecast 2026-2032

 Report
September 2026
189 Pages
Global

From

€3271EUR$3,545USD£2,762GBP

€3634EUR$3,939USD£3,069GBP

Kidney Cancer Therapeutics & Diagnostics Market Analysis & Forecast 2024-2034: Market By Cancer Type; By Component (Drugs (Therapeutic Class Pharmacologic Class, Diagnostics; By End-user; and By Region

 Report
October 2023
145 Pages
Global

From

€2906EUR$3,150USD£2,454GBP

Organ Transplant Immunosuppressant Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
August 2026
134 Pages
Global

From

€4382EUR$4,750USD£3,701GBP

Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
138 Pages
Global

From

€1845EUR$2,000USD£1,558GBP

Antibacterial Drugs Market - Global Forecast 2026-2032

 Report
September 2026
199 Pages
Global

From

€3271EUR$3,545USD£2,762GBP

€3634EUR$3,939USD£3,069GBP

Beta Lactam & Beta Lactamase Inhibitors Market - Global Forecast 2026-2032

 Report
September 2026
186 Pages
Global

From

€3271EUR$3,545USD£2,762GBP

€3634EUR$3,939USD£3,069GBP

CD137 Antibodies Clinical Trials & Market Opportunity Insight

 Report
September 2024
210 Pages
Global

From

€2214EUR$2,400USD£1,870GBP

Graft Versus Host Disease (GvHD) Treatment Market Forecast - Epidemiology & Pipeline Analysis 2022-2027

 Report
May 2022
190 Pages
Global

From

€3229EUR$3,500USD£2,727GBP

Endocrinology Drugs Market by Therapy Area, Distribution Channel, and By Region

 Report
March 2024
200 Pages
Global

From

€3829EUR$4,150USD£3,233GBP

Psoriasis Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
July 2026
120 Pages
Global

From

€4382EUR$4,750USD£3,701GBP

Psoriasis Drugs Market - Global Forecast 2026-2032

 Report
September 2026
199 Pages
Global

From

€3271EUR$3,545USD£2,762GBP

€3634EUR$3,939USD£3,069GBP

Psoriasis Treatment Market - Global Forecast 2026-2032

 Report
September 2026
199 Pages
Global

From

€3271EUR$3,545USD£2,762GBP

€3634EUR$3,939USD£3,069GBP

Vitiligo Therapeutics - Global Strategic Business Report

 Report
October 2026
224 Pages
Global

From

€5397EUR$5,850USD£4,558GBP

Atopic Dermatitis Drugs - Global Strategic Business Report

 Report
October 2026
351 Pages
Global

From

€5397EUR$5,850USD£4,558GBP

2,373 Results (Page 16 of 119)
- 1
- 14
- 15
- 16
- 17
- 18

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.